Chuck Soder
- Medtronic has acquired CardioInsight of Cleveland in a deal valued at $93 million. The local company’s technology is designed to diagnose electrical abnormalities affecting the heart. Thus, CardioInsight will become part of Medtronic’s Atrial Fibrillation Solutions business, according to a news release from Medtronic. The medical technology giant plans to maintain CardioInsight’s presence in Cleveland, according to an email statement attributed to Reggie Groves, vice president
↧
